Diebold Nixdorf, Incorporated
DBD
$75.36
-$2.12-2.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.86B | 3.81B | 3.69B | 3.67B | 3.70B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.86B | 3.81B | 3.69B | 3.67B | 3.70B |
| Cost of Revenue | 2.84B | 2.80B | 2.75B | 2.74B | 2.76B |
| Gross Profit | 1.02B | 1.00B | 940.20M | 934.10M | 935.40M |
| SG&A Expenses | 585.30M | 585.00M | 593.50M | 589.60M | 583.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.10M | -1.70M | -1.20M | 200.00K | -1.70M |
| Total Operating Expenses | 3.51B | 3.47B | 3.43B | 3.42B | 3.43B |
| Operating Income | 343.40M | 336.30M | 262.70M | 256.60M | 265.40M |
| Income Before Tax | 142.40M | 121.50M | 71.00M | 27.90M | 57.20M |
| Income Tax Expenses | 32.00M | 24.10M | 17.70M | 38.00M | 65.20M |
| Earnings from Continuing Operations | 110.40 | 97.40 | 53.30 | -10.10 | -8.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.50M | -2.80M | -2.70M | -2.80M | -2.20M |
| Net Income | 107.90M | 94.60M | 50.60M | -12.90M | -10.20M |
| EBIT | 343.40M | 336.30M | 262.70M | 256.60M | 265.40M |
| EBITDA | 457.10M | 452.50M | 394.20M | 387.00M | 394.80M |
| EPS Basic | 2.98 | 2.62 | 1.38 | -0.34 | -0.27 |
| Normalized Basic EPS | 4.10 | 3.64 | 2.29 | 1.90 | 2.30 |
| EPS Diluted | 2.94 | 2.58 | 1.37 | -0.34 | -0.28 |
| Normalized Diluted EPS | 4.05 | 3.59 | 2.27 | 1.89 | 2.30 |
| Average Basic Shares Outstanding | 144.60M | 147.10M | 148.90M | 150.00M | 150.40M |
| Average Diluted Shares Outstanding | 146.50M | 148.40M | 149.70M | 150.30M | 150.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |